Double-Masked, Placebo-Controlled Safety and Efficacy Trial of Diquafosol Tetrasodium (INS365) Ophthalmic Solution for the Treatment of Dry Eye von Tauber, J, Davitt, W F, Bokosky, J E, Nichols, K K, Yerxa, B R, Schaberg, A E, LaVange, L M, Mills-Wilson, M C, Kellerman, D J

Volltext

Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma von Li, James T.C., Ford, Linda B., Chervinsky, Paul, Weisberg, Stephen C., Kellerman, Donald J., Faulkner, Kenneth G., Herje, Nancy E., Hamedani, Abbas, Harding, Stuart M., Shah, Tushar

Volltext

Pharmacokinetic and Pharmacodynamic Characteristics and Safety of Inhaled Albuterol Enantiomers in Healthy Volunteers von Gumbhir-Shah, Kavita, Kellerman, Donald J., DeGraw, Sidney, Koch, Patrick, Jusko, William J.

Volltext

Fluticasone Propionate Improves Quality of Life in Patients with Asthma Requiring Oral Corticosteroids von Okamoto, Lynn J, Noonan, Michael, DeBoisblanc, Bennett P, Kellerman, Donald J

Volltext

Comparative Efficacy and Safety of Twice Daily Fluticasone Propionate Powder Versus Placebo in the Treatment of Moderate Asthma von Pearlman, David S, Noonan, Michael J, Tashkin, Donald P, Goldstein, Marc F, Hamedani, Abbas G, Kellerman, Donald J, Schaberg, Amy

Volltext

A 12-Week Dose-Ranging Study of Fluticasone Propionate Powder in the Treatment of Asthma von Wasserman, Stephen I., Gross, Gary N., Schoenwetter, William F., Munk, Zev M., Kral, K. M., Schaberg, A., Kellerman, D. J.

Volltext

Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine von Spierings, Egilius LH, Brandes, Jan Lewis, Kudrow, David B, Weintraub, James, Schmidt, Peter C, Kellerman, Donald J, Tepper, Stewart J

Volltext

Fluticasone Propionate Compared with Theophylline for Mild-to-Moderate Asthma von Galant, Stanley P, Lawrence, Michael, Meltzer, Eli O, Tomasko, Marilyn, Baker, Kimberly A, Kellerman, Donald J

Volltext

Dose-Related Response to Inhaled Fluticasone Propionate in Patients with Methacholine-Induced Bronchial Hyperresponsiveness: A Double-Blind, Placebo-Controlled Study von Noonan, Michael J., Chervinsky, Paul, Wolfe, James, Liddle, Roger, Kellerman, Donald J., Crescenzi, Kim L.

Volltext

Review of Acute Treatment of Migraine Trial Results With the New FDA Endpoints: Design Implications for Future Trials von Hindiyeh, Nada A., Kellerman, Donald J., Schmidt, Peter C.

Volltext

Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post‐Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial von Dodick, David W., Tepper, Stewart J., Friedman, Deborah I., Gelfand, Amy A., Kellerman, Donald J., Schmidt, Peter C.

Volltext

Pharmacokinetics and Pharmacodynamics of Cumulative Single Doses of Inhaled Salbutamol Enantiomers in Asthmatic Subjects von Gumbhir-Shah, Kavita, Kellerman, Donald J., DeGraw, Sidney, Koch, Patrick, Jusko, William J.

Volltext

Rapid systemic delivery of zolmitriptan using an adhesive dermally applied microarray von Kellerman, Donald J, Ameri, Mahmoud, Tepper, Stewart J

Volltext

Detection of Active Left Ventricular Thrombosis during Acute Myocardial Infarction Using Indium-111 Platelet Scintigraphy von Ezekowitz, Michael D., Kellerman, Don J., Smith, Eileen O., Streitz, Terri M.

Volltext

The Use of Oral Antihistamines (OA) in Moderate to Severe Dry Eye Patients von Kellerman, D.J

Volltext

Diquafosol tetrasodium: a novel dry eye therapy von Nichols, Kelly K, Yerxa, Ben, Kellerman, Donald J

Volltext

P2Y(2) receptor agonists: a new class of medication targeted at improved mucociliary clearance von Kellerman, Donald J

Volltext

Assessing acute systemic effects of an inhaled drug with serial echocardiography: a placebo-controlled comparison of inhaled and intravenous dihydroergotamine von Noveck, Robert J, Douglas, Pamela S, Chow, Shein-Chung, Mangum, Barry, Kori, Shashidhar, Kellerman, Donald J

Volltext

INS37217 Nasal Spray, a P2Y2 receptor agonist, as a novel treatment for common cold von Winther, B., Henry, D., Schaberg, A.E., Kuhn, K.L., Keyes-Elstein, L., Kellerman, D.J., Hayden, F.G.

Volltext

INS37217 intranasal, a P2Y2 receptor agonist, is a novel treatment for allergic rhinitis von Schaberg, A.E., Meltzer, E.O., LaForce, C.F., Pearlman, D.S., Ice, J.C., LaVange, L.M., Kellerman, D.J.

Volltext